Skip to main content
OpenTrials

Clinical trial condition

Secondary Hyperparathyroidism

Explore clinical trials studying Secondary Hyperparathyroidism. Study availability and eligibility vary by location and protocol.

99 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Secondary Hyperparathyroidism trial results

Completed

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

NCT01224782

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +15 more
Locations
  • Site Reference ID/Investigator# 66544 Montana, Bulgaria
  • Site Reference ID/Investigator# 47685 Pleven, Bulgaria
  • Site Reference ID/Investigator# 66546 Plovdiv, Bulgaria
  • Site Reference ID/Investigator# 47683 Sofia, Bulgaria
View all 69 locations
View Trial Details
Completed

Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)

NCT00823303

Conditions
Calcium Metabolism Disorders, Chronic Disease, Chronic Kidney Disease, +20 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Northshore University Health System Evanston, Illinois, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Completed

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

NCT01368042

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +15 more
Locations
  • Site Reference ID/Investigator# 56803 Arta, Greece
  • Site Reference ID/Investigator# 53424 Athens, Greece
  • Site Reference ID/Investigator# 53425 Larissa, Greece
  • Site Reference ID/Investigator# 56805 Lefkada, Greece
View Trial Details
Completed

Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease

NCT00261950

Conditions
Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site New Haven, Connecticut, United States
View all 55 locations
View Trial Details
Completed

Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years

NCT01073462

Conditions
Cardiac Morbidity, Chronic Disease, Chronic Kidney Disease Stage V, +16 more
Locations
  • Site Reference ID/Investigator# 27447 Graz, Austria
  • Site Reference ID/Investigator# 49182 Graz, Austria
  • Site Reference ID/Investigator# 27483 Graz, Austria
  • Site Reference ID/Investigator# 52742 Graz, Austria
View Trial Details
Completed

Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation

NCT01401478

Conditions
Chronic Disease, Disease Attributes, Endocrine System Diseases, +14 more
Locations
  • Site Reference ID/Investigator# 57348 Al'met'yevsk, Russia
  • Site Reference ID/Investigator# 57347 Cheboksary, Russia
  • Site Reference ID/Investigator# 58347 Chelyabinsk, Russia
  • Site Reference ID/Investigator# 67404 Iakutsk, Russia
View all 13 locations
View Trial Details
Completed

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

NCT01265992

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +29 more
Locations
  • Site Reference ID/Investigator# 47723 Kalmar, Sweden
  • Site Reference ID/Investigator# 41084 Karlstad, Sweden
  • Site Reference ID/Investigator# 45190 Kristianstad, Sweden
  • Site Reference ID/Investigator# 41085 Linköping, Sweden
View Trial Details

Related conditions